About MO BIO Laboratories
MO BIO Laboratories is a Healthcare company based in Carlsbad (United States) founded in 1993, and was acquired by Qiagen in January 2016. Provider of molecular diagnostic solutions. The company was acqui-hired. Its focus areas include Life Sciences, Genomics, Enabling Technologies and Kits and Reagents. Its competitors include GenScript and Molecular Assemblies; 2 of its 2 listed competitors have raised funding.
Company details
Founded in 1993 and based in Carlsbad, United States, MO BIO Laboratories operates in the molecular diagnostics sector. Patented Inhibitor Removal Technology is employed to isolate pure DNA from difficult samples, including soil, water, plants, and stool. Kits developed by the company are applied in microbiome research projects, such as the Earth Microbiome Project and the NIH-funded Human Microbiome Project, where PCR inhibitors are commonly present.
Investors in MO BIO Laboratories
MO BIO Laboratories has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Qiagen.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Products and reagents for molecular diagnostic assays are supplied. | 1984 | qiagen.com | Hilden, Germany |
Investor details for MO BIO Laboratories
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of MO BIO Laboratories
2 dated milestones of MO BIO Laboratories across 23 years, from founding to its latest funding, stage changes and deals.
- Founded MO BIO Laboratories is founded.
- Exit Acquired by Qiagen.
Competitors of MO BIO Laboratories
MO BIO Laboratories has 2 listed competitors in our database, 2 of them funded. They include GenScript and Molecular Assemblies.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| genscript.com | 2002 | Piscataway, United States | $15M | 5,260 | Reagents and instruments are provided for life sciences research. | |
| molecularassemblies.com | 2013 | San Diego, United States | $78.48M | 21 | Enzymatic DNA synthesis products are provided for researchers. |
Detailed competitors of MO BIO Laboratories
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of MO BIO Laboratories
Websites that share an audience with MO BIO Laboratories (mobio.com).
Websites whose visitors overlap most with MO BIO Laboratories. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| kreatech.com | 81% | View details | |||
| clontech.com | 80% | View details | |||
| transnetyx.com | 78% | 88.6K | #236,504 | View details | |
| genisphere.com | 74% | View details | |||
| dianova.com | 73% | 6.5K | #3,245,925 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 8 similar websites and full traffic analytics for MO BIO Laboratories
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 8 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as MO BIO Laboratories (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Mo Bio Laboratories
Complete news archive for MO BIO Laboratories
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MO BIO Laboratories
MO BIO Laboratories was founded in 1993.
MO BIO Laboratories is headquartered in Carlsbad, United States. It is registered at Carlsbad, California, United States.
Founded in 1993 and based in Carlsbad, United States, MO BIO Laboratories operates in the molecular diagnostics sector. Patented Inhibitor Removal Technology is employed to isolate pure DNA from difficult samples, including soil, water, plants, and stool. Kits developed by the company are applied in microbiome research projects, such as the Earth Microbiome Project and the NIH-funded Human Microbiome Project, where PCR inhibitors are commonly present.
MO BIO Laboratories's top competitors include GenScript and Molecular Assemblies.
MO BIO Laboratories has 1 investor. Key investors include Qiagen.
Yes. MO BIO Laboratories was acquired by Qiagen in January 2016.